See what’s happening at MBC BioLabs.
2025 Astellas Future Innovator Prize Awarded to DeepSeq.AI & Serna Bio
The award, now in its sixth year, offers entrepreneurial scientists, emerging startups and small biotechs one-year priority usage of MBC BioLabs’ state-of-the-art lab facility in the San Francisco Bay Area, as well as access to Astellas’ research and development capabilities and business leaders.
ONO Golden Ticket 2025
ONO PHARMA USA announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco and San Carlos, CA to award each organization one Golden Ticket for an innovative life sciences startup company.
Interested applicants may submit their non-confidential company presentations by June 6.
Astellas Future Innovator Prize 2025
Astellas Pharma U.S. Inc., and MBC BioLabs announced their collaboration on the Astellas Future Innovator Prize. The competition offers entrepreneurial scientists and emerging biotechnology start-ups one year’s priority usage of MBC BioLabs’ state-of-the-art Bay Area facilities and access to Astellas’ research and development capabilities and business leaders.
Proposals due by April 1, 2025
The award, now in its sixth year, offers entrepreneurial scientists, emerging startups and small biotechs one-year priority usage of MBC BioLabs’ state-of-the-art lab facility in the San Francisco Bay Area, as well as access to Astellas’ research and development capabilities and business leaders.
ONO PHARMA USA announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco and San Carlos, CA to award each organization one Golden Ticket for an innovative life sciences startup company.
Interested applicants may submit their non-confidential company presentations by June 6.
Astellas Pharma U.S. Inc., and MBC BioLabs announced their collaboration on the Astellas Future Innovator Prize. The competition offers entrepreneurial scientists and emerging biotechnology start-ups one year’s priority usage of MBC BioLabs’ state-of-the-art Bay Area facilities and access to Astellas’ research and development capabilities and business leaders.
Proposals due by April 1, 2025
A Spotlight on Siolta Therapeutics
Siolta Therapeutics vision was bold and prevention-focused: to prevent allergic diseases in infants before symptoms ever appear – not to manage them or treat them after diagnosis, but to stop them from developing in the first place. This year, that vision became reality.
Fika, A New MBC BioLabs Tradition!
According to Doug Crawford, there are a few key things that scientists need in order to succeed in the labs: one of them being coffee, and the other is snacks! Our newly adapted weekly tradition of Fika was inspired by the Swedish culture. Fika, which roughly translates from Swedish as drinking coffee, munching sweet treats and chatting — is as much a part of the working day in Sweden as emailing and fixing the printer.
